We are live on
!
Find out more
SC
Scholtz & Company Portfolio holdings
AUM
$200M
1-Year Est. Return
12.67%
This Fund
S&P 500
This Quarter
Est. Return
+11.78%
1 Year Est. Return
+12.67%
3 Year Est. Return
+89.15%
5 Year Est. Return
+104.79%
10 Year Est. Return
+863.86%
AUM
$160M
AUM Growth
+$19.7M
(+14%)
Cap. Flow
+$5.39M
Cap. Flow
% of AUM
3.37%
Top 10 Holdings %
Top 10 Hldgs %
58.47%
Holding
42
New
8
Increased
10
Reduced
21
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$3.42M |
| 2 |
Adobe
ADBE
|
+$3.13M |
| 3 |
Fortinet
FTNT
|
+$2.45M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$2.23M |
| 5 |
Zoetis
ZTS
|
+$2.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$6.03M |
| 2 |
W.R. Berkley
WRB
|
+$1.99M |
| 3 |
Morgan Stanley
MS
|
+$1.91M |
| 4 |
Microsoft
MSFT
|
+$1.05M |
| 5 |
Marvell Technology
MRVL
|
+$637K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.7% |
| 2 | Consumer Discretionary | 21.83% |
| 3 | Healthcare | 16.15% |
| 4 | Financials | 14.34% |
| 5 | Industrials | 13.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
W.R. Berkley
WRB
$26.5B
| $1.64M | 1.03% |
41,400
-50,580
| -55% | -$1.99M |
|
27
TSMC
TSM
$2.15T
| $1.64M | 1.02% |
16,214
-916
| -5% | -$85.2K |
|
|
28
Marvell Technology
MRVL
$199B
| $1.58M | 0.99% |
26,505
-13,102
| -33% | -$637K |
|
|
XRN
29
Chiron Real Estate Inc
XRN
$478M
| $1.5M | 0.94% |
32,951
-1,051
| -3% | -$47.5K |
|
30
ASML
ASML
$611B
| $1.5M | 0.94% |
+2,068
| New | +$1.41M |
|
31
Air Products & Chemicals
APD
$64.7B
| $1.49M | 0.93% |
4,957
-171
| -3% | -$48.7K |
|
32
NVIDIA
NVDA
$5.12T
| $924K | 0.58% |
+21,840
| New | +$725K |
|
33
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $505K | 0.32% |
1,140
-106
| -9% | -$44.5K |
|
34
NextEra Energy
NEE
$169B
| $260K | 0.16% |
3,510
-30
| -0.8% | -$2.27K |
|
35
Lamar Advertising Co
LAMR
$15B
| $255K | 0.16% |
2,572
+13
| +0.5% | +$1.26K |
|
36
Merck
MRK
$355B
| $214K | 0.13% |
+1,854
| New | +$211K |
|
37
Hershey
HSY
$34.2B
| $212K | 0.13% |
850
+30
| +4% | +$7.87K |
|
38
Apyx Medical
APYX
$125M
| $75K | 0.05% |
15,000
+5,000
| +50% | +$25.3K |
|
|
INTZ
39
DELISTED
INTRUSION INC NEW
INTZ
| $12K | 0.01% |
+10,000
| New | +$12K |
|
|
40
Morgan Stanley
MS
$324B
| – | – |
-21,737
| Closed | -$1.91M |
|
41
MSCI
MSCI
$39.6B
| – | – |
-591
| Closed | -$331K |
|
|
42
Northrop Grumman
NOC
$75.5B
| – | – |
-13,054
| Closed | -$6.03M |
|
Similar funds
FFG
MSRI
MCM
TDB
CPP
BBFA
DI
JHWEPV
Scholtz & Company's Q2 2023 Portfolio in Review
As of Q2 2023, Scholtz & Company held 42 positions worth $160M, up 14% from $140M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Scholtz & Company deployed $5.39M of net new capital in Q2 2023, opening 8 new positions and adding to 10 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 12,304 shares worth $3.51M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was W.R. Berkley, an estimated $1.99M trimmed.
- Scholtz & Company's largest Q2 2023 buy was Shockwave Medical, Inc. Common Stock: 12,304 shares worth $3.51M.
- Scholtz & Company added most to Zoetis in Q2 2023, an estimated $2.01M increase.
- Scholtz & Company's biggest Q2 2023 reduction was W.R. Berkley, cutting an estimated $1.99M.
- Scholtz & Company fully exited Northrop Grumman in Q2 2023, selling an estimated $6.03M.
- Scholtz & Company's ten largest holdings make up 58% of its $160M portfolio in Q2 2023.
- Scholtz & Company opened 8 new positions and closed 3 in Q2 2023.
- Scholtz & Company's portfolio value rose 14% quarter-over-quarter to $160M.
Based on Scholtz & Company's 13F filing for Q2 2023, filed 14 Aug 2023.